<table border="1"><tr><th>Name UICPA</th><td><ul><li>2,2-dichloro-N-[1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide</li></ul></td></tr><tr><th>N | o | CAS</th><td><ul><li>56-75-7</li></ul></td></tr><tr><th>N | o | ECHA</th><td><ul><li>100,000.262</li></ul></td></tr><tr><th>N | o | EC</th><td><ul><li>200-287-4</li></ul></td></tr><tr><th>ATC Code</th><td><ul><li>D06 | AX02 | D10 | AF03 | G01 | AA05 | J01 | BA01 | S01 | AA01 | S02 | AA01 | S03 | AA08</li></ul></td></tr><tr><th>DrugBank</th><td><ul><li>DB00446</li></ul></td></tr><tr><th>PubChem</th><td><ul><li>5959</li></ul></td></tr><tr><th>SMILES</th><td><ul><li>C1=CC(=CC=C1C(C(CO)NC(=O)C(Cl)Cl)O)([N+](=O)[O-] | PubChem |, | 3D view</li></ul></td></tr><tr><th>InChI</th><td><ul><li>InChI | 3D view | InChI=1/C11H12Cl2N2O5/c12-10(13)11(18)14-8(5-16)9(17)6-1-3-7(4-2-6)15(19)20/h1-4.8-10.16-17H.5H2,(H.14.18)/t8-.9-/m1/s1/f/h14H</li></ul></td></tr><tr><th>Appearance</th><td><ul><li>white powder</li></ul></td></tr><tr><th>Formula</th><td><ul><li>C | 11 | H | 12 | CL | 2 | N | 2 | O | 5 | [Isomeres]</li></ul></td></tr><tr><th>Molar mass</th><td><ul><li>323.129 ± 0.016 g/mol | C 40.89 %, H 3.74%, Cl 21.94 %, N 8.67%, O 24.76 %,</li></ul></td></tr><tr><th>T° | fusion</th><td><ul><li>150,5 | °C</li></ul></td></tr><tr><th>Solubility</th><td><ul><li>2.5 | g | · L | -1 | water to | 25 | °C |. | 5 to | 20 | mg | · mL | -1 | absolute ethanol. | 150.8 | mg | · mL | -1 | propylene glycol. | Soil in methanol, ethanol, butanol, acetone and ethyl acetate. | Little soil in ether. | Insol. in benzene, petroleum ether.</li></ul></td></tr><tr><th>IARC Classification</th><td><ul><li>Group 2A: Probably Carcinogenic for Man</li></ul></td></tr><tr><th>DL | 50</th><td><ul><li>1,500 | mg | · | kg | -1 | oral mice | 110 | mg | | kg | -1 | i.v. mice | 400 | mg | · kg | -1 | s.c. mice | 1 100 | mg | · | kg | -1 | i.p. mice</li></ul></td></tr><tr><th>Metabolism</th><td><ul><li>hepatic</li></ul></td></tr><tr><th>Half-life of | elim.</th><td><ul><li>2 | h | 30</li></ul></td></tr><tr><th>Excretion</th><td><ul><li>reins (5-15 %), feces 4%</li></ul></td></tr><tr><th>Therapeutic class</th><td><ul><li>bacteriostatic</li></ul></td></tr><tr><th>Oral, intramuscular and intravenous administration</th><td><ul><li></li></ul></td></tr></table>